Company Description
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally.
The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.
It provides Carepoint devices comprising carts, peripherals, tablets, and TVs, which serve as digital access points in clinical settings.
In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, acute psychiatry, lactation counseling, and nutrition services.
Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services.
The company sells its products through field sales professionals, channel partners, and value-added resellers.
American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
| Country | United States |
| Founded | 2006 |
| IPO Date | Sep 17, 2020 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 1,104 |
| CEO | Dr. Ido Schoenberg M.D. |
Contact Details
Address: 75 State Street, 26th Floor Boston, Massachusetts 02109 United States | |
| Phone | 617-205-3500 |
| Website | amwell.com |
Stock Details
| Ticker Symbol | AMWL |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $18.00 |
| CIK Code | 0001393584 |
| CUSIP Number | 03044L105 |
| ISIN Number | US03044L1052 |
| SIC Code | 7389 |
Key Executives
| Name | Position |
|---|---|
| Dr. Ido Schoenberg M.D. | Chairman and Co-Chief Executive Officer |
| Dr. Roy Schoenberg M.D., M.P.H. | President, Co-Chief Executive Officer and Director |
| Robert Shepardson | Chief Financial Officer |
| Kurt Knight | Chief Operating Officer |
| Vukasin Paunovich | Executive Vice President of Enterprise Platforms |
| Phyllis I. Gotlib | President of Amwell International |
| Paul Francis McNeice | Vice President of Accounting |
| Tim Conway | Chief Information Officer |
| Sue Dooley | Head of Investor Relations |
| Bradford F. Gay | Senior Vice President and General Counsel |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 1, 2024 | 144 | Filing |
| May 1, 2024 | 144 | Filing |
| May 1, 2024 | 10-Q | Quarterly Report |
| May 1, 2024 | 8-K | Current Report |
| Apr 26, 2024 | ARS | Filing |
| Apr 26, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 26, 2024 | DEF 14A | Other definitive proxy statements |
| Apr 16, 2024 | PRE 14A | Other preliminary proxy statements |
| Apr 4, 2024 | 8-K | Current Report |
| Apr 1, 2024 | 144 | Filing |